These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25727319)

  • 21. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
    Kanno T; Takahashi T; Tsujisawa T; Ariyoshi W; Nishihara T
    J Cell Biochem; 2007 Aug; 101(5):1266-77. PubMed ID: 17265428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for Runx2 in normal mammary gland and breast cancer bone metastasis.
    Shore P
    J Cell Biochem; 2005 Oct; 96(3):484-9. PubMed ID: 16052475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone.
    Mak IW; Cowan RW; Popovic S; Colterjohn N; Singh G; Ghert M
    Bone; 2009 Aug; 45(2):377-86. PubMed ID: 19422937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Potential Role of RUNX2- RUNT Domain in Modulating the Expression of Genes Involved in Bone Metastases: An In Vitro Study with Melanoma Cells.
    Deiana M; Dalle Carbonare L; Serena M; Cheri S; Mutascio S; Gandini A; Innamorati G; Lorenzi P; Cumerlato M; Bertacco J; Antoniazzi F; Romanelli MG; Mottes M; Zipeto D; Valenti MT
    Cells; 2020 Mar; 9(3):. PubMed ID: 32204402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RUNX2 and Cancer.
    Lin TC
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUNX2 as a Prognostic Factor in Human Cancers.
    Toner J; Gordon JAR; Greenyer H; Kaufman P; Stein JL; Stein GS; Lian JB
    Crit Rev Eukaryot Gene Expr; 2024; 34(7):51-66. PubMed ID: 39072409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Runx2 and Its Signaling Pathways by MicroRNAs in Breast Cancer Metastasis.
    Pranavkrishna S; Sanjeev G; Akshaya RL; Rohini M; Selvamurugan N
    Curr Protein Pept Sci; 2021; 22(7):534-547. PubMed ID: 33200704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.
    Deiana M; Dalle Carbonare L; Serena M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Manfredi M; Marengo E; Brandi J; Cecconi D; Mori A; Mina MM; Antoniazzi F; Mottes M; Tiso N; Malerba G; Zipeto D; Valenti MT
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RUNX2 as a promising therapeutic target for malignant tumors.
    Zhao W; Yang H; Chai J; Xing L
    Cancer Manag Res; 2021; 13():2539-2548. PubMed ID: 33758548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent advances in Runx2 research].
    Takarada T
    Nihon Yakurigaku Zasshi; 2014 Aug; 144(2):98. PubMed ID: 25109524
    [No Abstract]   [Full Text] [Related]  

  • 32. Wrong place, wrong time: Runt-related transcription factor 2/SATB2 pathway in bone development and carcinogenesis.
    Zhu Y; Ortiz A; Costa M
    J Carcinog; 2021; 20():2. PubMed ID: 34211338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Runx2 expression: A mesenchymal stem marker for cancer.
    Valenti MT; Serafini P; Innamorati G; Gili A; Cheri S; Bassi C; Dalle Carbonare L
    Oncol Lett; 2016 Nov; 12(5):4167-4172. PubMed ID: 27895787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERRATUM to Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer: Epigenetic control of the
    Tumour Biol; 2019 Aug; 41(8):1010428319867499. PubMed ID: 31451094
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of RUNX2 in Breast Carcinogenesis.
    Wysokinski D; Blasiak J; Pawlowska E
    Int J Mol Sci; 2015 Sep; 16(9):20969-93. PubMed ID: 26404249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression.
    Cohen-Solal KA; Boregowda RK; Lasfar A
    Mol Cancer; 2015 Jul; 14():137. PubMed ID: 26204939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RUNX2 and Osteosarcoma.
    Li N; Luo D; Hu X; Luo W; Lei G; Wang Q; Zhu T; Gu J; Lu Y; Zheng Q
    Anticancer Agents Med Chem; 2015; 15(7):881-7. PubMed ID: 25738872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between Molecular Mechanisms and Tooth Eruption in Children with Obesity.
    Traver C; Miralles L; Barcia JM
    Children (Basel); 2022 Aug; 9(8):. PubMed ID: 36010098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA.
    Sa R; Liang R; Qiu X; He Z; Liu Z; Chen L
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transitional cell carcinoma matrix stiffness regulates the osteopontin and YAP expression in recurrent patients.
    Ghasemi H; Mousavibahar SH; Hashemnia M; Karimi J; Khodadadi I; Tavilani H
    Mol Biol Rep; 2021 May; 48(5):4253-4262. PubMed ID: 34086159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.